Answers are grounded in this paper and cite their sources.
Early identification of clinically significant valvular heart disease (VHD) remains challenging because echocardiography is resource-intensive and conventional auscultation is operator-dependent. Artificial intelligence (AI)-enabled analysis of digital heart sounds has emerged as a promising screening strategy, but its overall diagnostic performance has not been systematically evaluated. We conducted a Preferred Reporting Items for Systematic Reviews and Meta-Analyses of Diagnostic Test Accuracy studies-compliant systematic review and diagnostic test accuracy meta-analysis of studies evaluating AI-enabled cardiac auscultation against transthoracic echocardiography for detecting clinically significant VHD, defined according to each study's echocardiographic criteria. MEDLINE, Embase, and CENTRAL were searched through July 2026, and pooled sensitivity, specificity, summary receiver operating characteristic area under the curve, diagnostic odds ratio, and accuracy were estimated using random-effects models. Eight studies comprising 4374 analyzed participants were included. AI-enabled cardiac auscultation demonstrated a pooled sensitivity of 72% (95% CI 54-85%) and specificity of 82% (95% CI 74-88%) for detecting clinically significant VHD. The summary receiver operating characteristic area under the curve was 0.814 (95% CI 0.569-0.888), and the pooled diagnostic odds ratio was 11.39 (95% CI 3.76-34.47), corresponding to positive and negative likelihood ratios of approximately 4.0 and 0.34, respectively. Overall pooled diagnostic accuracy was 78% (95% CI 67-86%). Subgroup analyses demonstrated substantially higher sensitivity for studies evaluating isolated aortic stenosis than composite VHD (92% vs. 55%; P < 0.001), whereas specificity was comparable. AI-enabled cardiac auscultation demonstrates promising diagnostic performance for identifying clinically significant VHD and may serve as a front-line screening tool to prioritize patients for echocardiography. Future prospective multicenter studies using standardized recording protocols and external validation are needed before widespread clinical implementation.
No takes yet. Share an insight, caveat, or question.
Saeed et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: